Literature DB >> 18651827

Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.

Tracy S Wang1, Idris Tolgay Ocal, Julie Ann Sosa, Heather Cox, Sanziana Roman.   

Abstract

Calcitonin is a sensitive tumor marker for medullary thyroid cancer (MTC) and is useful in preoperative diagnosis and postoperative surveillance for recurrent disease. Calcitonin-negative MTC is a rare occurrence. We present the case of a 68-year-old man with a 6.5 cm sporadic MTC with a 5-cm metastasis in the neck, but only minimally elevated serum calcitonin levels. He underwent total thyroidectomy, resection of internal jugular vein, and limited ipsilateral lymph node dissection. He remains disease-free 12 months after surgery. We review the literature on calcitonin-negative MTC and discuss methods of postoperative surveillance in this subset of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651827     DOI: 10.1089/thy.2007.0413

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  15 in total

1.  Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.

Authors:  Allen S Ho; Lu Wang; Frank L Palmer; Changhong Yu; Arnbjorn Toset; Snehal Patel; Michael W Kattan; R Michael Tuttle; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2014-11-04       Impact factor: 5.344

2.  Calcitonin-negative neuroendocrine tumor of thyroid gland mimicking anaplastic carcinoma: an unusual entity.

Authors:  Onur Ismi; Rabia Bozdogan Arpaci; Mustafa Berkesoglu; Ahmet Dag; Emel Sezer; Kemal Koray Bal; Yusuf Vayısoğlu
Journal:  Gland Surg       Date:  2015-08

Review 3.  Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.

Authors:  Giuseppe Costante; Cosimo Durante; Zélia Francis; Martin Schlumberger; Sebastiano Filetti
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

4.  Clinical utility gene card for: multiple endocrine neoplasia type 2.

Authors:  Friedhelm Raue; Susanne Rondot; Egbert Schulze; Sylwia Szpak-Ulczok; Barbara Jarzab; Karin Frank-Raue
Journal:  Eur J Hum Genet       Date:  2011-08-24       Impact factor: 4.246

Review 5.  Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.

Authors:  Giuseppe Costante; Domenico Meringolo
Journal:  Endocrine       Date:  2020-01-10       Impact factor: 3.633

6.  The calcitonin levels can sometimes mislead parathyroid surgeons in patients with chronic kidney disease and renal hyperparathyroidism: report of a case.

Authors:  Ralph Schneider; Johanna E Schaumburg; Detlef K Bartsch; Katja Schlosser
Journal:  Surg Today       Date:  2013-04       Impact factor: 2.549

7.  Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.

Authors:  Daisy V Alapat; Kenneth B Ain; David A Sloan; Kristin G Monaghan; Rouzan G Karabakhtsian
Journal:  Endocrine       Date:  2011-01-18       Impact factor: 3.633

Review 8.  Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

Authors:  Maria Teresa Samà; Ruth Rossetto Giaccherino; Marco Gallo; Francesco Felicetti; Francesca Maletta; Nadia Bonelli; Alessandro Piovesan; Nicola Palestini; Ezio Ghigo; Emanuela Arvat
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-28       Impact factor: 4.553

9.  Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Authors:  Hans Hg Verbeek; Jan Willem B de Groot; Wim J Sluiter; Anneke C Muller Kobold; Edwin R van den Heuvel; John Tm Plukker; Thera P Links
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

10.  Calcitonin-negative neuroendocrine tumor of the thyroid with metastasis to liver-rare presentation of an unusual tumor: A case report and review of literature.

Authors:  Huai-Jie Cai; Han Wang; Nan Cao; Bin Huang; Fan-Lei Kong; Li-Ren Lu; Ya-Yuan Huang; Wei Wang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.